Aquestive Therapeutics Inc., a Warren-based specialty pharmaceutical company, has named a new general counsel, it said Tuesday.
Lori J. Braender, formerly of Day Pitney LLP, started as the firm’s senior vice president, as well as general counsel, on Monday.
“We are pleased to welcome Lori,” Keith J. Kendall, CEO, said in a prepared statement. “With her knowledge and familiarity of the company, and the depth of her professional experience, Lori will be an important part of the leadership of Aquestive.”
Braender had been with Day Pitney for 35 years, most recently as chair of the Life Sciences Practice Group.
“I’m honored to join the Aquestive team,” she said in a statement. “The company’s unique business model and technology deliver meaningful solutions to patients, and I look forward to contributing to the success of these efforts.”
